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Skin Ca2+-binding protein (SCaBP) was reported to be distinct from the Ca2+-binding parvalbumin (PV), 
however, more recently its amino acid sequence was shown to be identical to PV. We purified a protein 
(M, 12000; ~14.5) from isolated epidermis (free of other cell layers) of adult rats and whole skin (containing 
no PV) of newborn rats. This protein is referred to as epidermal protein (EP-12) distinct from PV in its 
hydrophobicity, amino acid composition and immunological properties. Previously isolated SCaBP was 
shown to be a mixture of EP-12 and PV. The localization and possible functions of EP-12 and of PV in 
skin of adult and newborn rat are discussed. 
Ca2+-binding protein; Parvalbumin; (Skin, Epidermis) 
1. INTRODUCTION 
Ca2+ and Ca2+-binding proteins (e.g. calmodu- 
lin) may be involved in regulating the proliferation 
of many somatic cells [ 1,2]. The epidermis is one 
of the most rapidly proliferating normal tissues 
and therefore was chosen to study the involvement 
of Ca2’ and Ca’+-binding proteins in the control 
of cell proliferation. 
To date, two Ca2+-binding proteins have been 
described in the epidermis: S-100 proteins are 
localized in melanocytes and Langerhans cells [3] 
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and calmodulin in all keratinocytes [4,5]. There is, 
however, a controversy about a third skin 
Ca2+-binding protein (SCaBP) [6-81 reported to 
be present in the proliferating layer of the epider- 
mis [9] and suggested to be a marker for tumors of 
epidermoid origin [lo]. 
SCaBP was reported to be biochemically and 
immunologically distinct from the Ca’+-binding 
parvalbumin (PV) [6], however, more recently its 
amino acid sequence was shown to be identical to 
PV (81. Originally, these proteins were isolated 
from whole rat skin, composed of epidermis, der- 
mis and subcutaneous tissues (mainly muscle). We 
purified a protein (Mr 12000; ~14.5) from isolated 
epidermis (free of other cell layers) of adult rats 
and from whole skin (containing no PV) of 
newborn rats. This protein is referred to as epider- 
ma1 protein (EP-12), distinct from PV in its 
hydrophobicity, amino acid composition and im- 
munological properties. Previously isolated 
SCaBP was shown to be a mixture of EP-12 and 
PV. EP-12 bound 45Ca in a Ca/transblot assay on- 
ly when high protein concentrations were applied, 
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suggesting a lower affinity for Ca2+ than PV. The 
localization and possible functions of EP-12 and 
of PV in skin of adult and newborn rats are 
discussed. 
2. MATERIALS AND METHODS 
2.1. Isolation of proteins 
Parvalbumin was purified from rat muscle [l l] 
and calmodulin (CaM) from ox brain [12]. SCaBP 
was prepared from whole skin [6] of adult male 
Wistar rats (250-300 g). Final purification was 
done by reverse-phase HPLC fitted with an 
Aquapore RP-300 column (particle size, 10pm; 
pore size, 300 A; Brownlee Labs, Santa Clara, 
CA) [ 111. Proteins were eluted with a linear gra- 
dient of acetonitrile (Fluka) in 25 mM Tris-HCl 
(pH 7.4), 0.1 mM EGTA. The fractions under 
each peak were pooled and stored at - 80°C. 
EP-12 was isolated from the epidermis of adult 
male rats prepared free of underlying tissue 
layers. Epidermis was separated from the dermis 
by heating whole skin in 0.9% NaCl for 1 min at 
52°C. It was then homogenized in 13 mM Tris- 
HCl, 4 mM PMSF, pH 7.8, in a Polytron 
homogenizer (2 min, max. speed), passed through 
a molecular size membrane (fluoropolymer, 
0.2pm, Gelman Sciences Inc.), and subjected to 
HPLC as described above. 
EP-12 was also isolated from the skin of 
newborn rats, according to [6] with the following 
modifications: gel filtration of the initial extract on 
Sephadex G-75 rather than Sepharose CL6B 
followed by fractionation on Sephacryl S-200 and 
final purification on HPLC under conditions 
described above. 
2.2. Antibodies 
Antisera against rat muscle parvalbumin [ 181 
and SCaBP were raised in rabbits [ 131. Antibodies 
to EP-12 were prepared in rabbits: initial intrader- 
ma1 injection of 1OOcg EP-12 in 1 ml of 0.9% 
NaCl emulsified with 1 ml Freund’s complete ad- 
juvant, followed by subcutaneous injections of 
50 pg EP-12 in incomplete Freund’s adjuvant at 
2-week intervals. Specificity was checked by im- 
munoblotting. 
2.3. Immunoblotting 
Proteins were separated by SDS-PAGE (15% 
22 
gels) and transferred to nitrocellulose sheets [14]. 
All primary antisera were diluted 1:2000, the 
secondary antiserum, peroxidase-labeled goat anti- 
rabbit IgG (Miles) was diluted 1: 1000. Proteins 
were located by reacting with chloronaphthol 
(0.01@70) and hydrogen peroxide (0.001 (r/o). 
2.4. Dot-immunobinding assay 
This method is described in [15]. Primary an- 
tisera were diluted 1: 2000 and peroxidase-labeled 
goat anti-rabbit IgG was diluted 1: 1000. Incuba- 
tion with the primary antibody was for 2 h at room 
temperature. Reactions were visualized with 
chloronaphthol as above. 
2.5. Two-dimensional SDS-PAGE 
Purified proteins and skin extracts were labeled 
in vitro by reductive methylation ([14C]- 
formaldehyde, NEN, spec. act. 52 Ci/mol), 
separated by two-dimensional PAGE and visual- 
ized by fluorography. 
2.6. Amino acid analysis 
Analyses were performed on a Hitachi 835-50 
analyser. EP-12 was hydrolyzed in trifluoroacetic 
acid/cone. HCl(1: 2, v/v) containing 0.2% phenol 
at 170°C for 25, 35 and 45 min in evacuated sealed 
tubes [16]. The vahtes for threonine and serine 
were obtained by extrapolation to zero time. All 
other values are the averages of three hydrolyses. 
2.7. 4sCa-overlay transblotting 
Calcium binding to proteins was demonstrated 
as described in [17]. Proteins were first separated 
by SDS-PAGE (15%) and then transferred elec- 
trophoretically to a nitrocellulose membrane 
(Schleicher & Schiill membrane filter, 0.45 am). 
The membrane was incubated with 45Ca (NEN, 
spec. act. 1 mCi/mmol). Calcium-binding proteins 
were visualized by autoradiography. 
2.8. Immunohistochemistry 
Full details of the methods used are given in 
[18]. EP-12 distribution in newborn rat skin was 
studied after perfusion-fixation with Bouin’s fluid 
and paraffin embedding. Adult rat skin was fixed 
by freeze substitution. Primary antisera were 
diluted 1:2500 (anti-PV) or 1: 5000 (anti-EP-12). 
Affinity-purified anti-EP-12 was diluted 1 : 2000; 
goat anti-rabbit IgG (Miles) was diluted 1:300; 
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rabbit peroxidase-anti-peroxidase (PAP) complex 
(Sternberger Meyer, Inc.) was diluted 1:200. The 
peroxidase substrate was diaminobenzidine 
(0.04%, Polysciences) and Hz02 (0.004%): reac- 
tion time was 15-30 min at room temperature. 
3. RESULTS 
3.1. Isolation of EP-12 
3.1.1. From SCaBP 
HPLC of SCaBP produced two major peaks 
(not shown). One, eluting at 60% buffer B, was 
identified as PV by its elution position, 2D PAGE 
analysis and immunoblotting. The second protein, 
eluting at 50% buffer B, did not cross-react with 
antibodies to PV and was designated EP-12 as it 
has an apparent A& on SDS-PAGE of 12000. 
3.1.2. From newborn rat skin 
EP-12 was prepared from the skin of newborn 
rats by gel filtration followed by HPLC on reverse- 
phase supports. The EP-12 showed the same elu- 
tion characteristics and migrated in exactly the 
same position on SDS-PAGE as EP-12 prepared 
from SCaBP. It showed no cross-reactivity with 
antibodies to PV or CaM. 
3.1.3. HPLC of adult rat epidermis extracts 
Aqueous extracts of rat epidermis were sub- 
jected to HPLC (fig.1). One peak eluted at the 
same position as purified EP-12, the second and 
third peaks were identified as calmodulin and PV 
by their elution positions on HPLC, their migra- 
tion on SDS-PAGE and their immunoreactivity. 
The EP-12 peak showed no cross-reaction with an- 
tibodies to either PV or CaM. 
3.2. Characterization of EP-12 
3.2.1. Elution from HPLC 
Fig.2 shows the elution patterns of two prepara- 
tions of EP-12 compared to PV and CaM. EP-12 
was well separated from PV, but ran close to CaM: 
EP-12 prepared from adult rat epidermis and 
whole skin of newborn rats eluted in identical posi- 
tions. EP-12 appeared to be somewhat unstable, as 
indicated by the asymmetry of the HPLC peak. A 
second, minor band (Mr approx. 10000) was 
observed on SDS-PAGE (fig.3a) and the quantity 
of this component increased with time in storage. 
100% B, 
0,005 
I 
2 min 
- 
Fig.1. HPLC of a Tris-HCI extract of rat epidermis 
(500 pg). A Tris-HCl/EGTA, pH 7.4, buffer system was 
used. The gradient was O-100% buffer B in 15 min. 
EP-12 was well separated from PV. EP-12, epidermal 
protein (Mr 12000); PV, parvalbumin; CaM, 
calmodulin. 
3.2.2. SDS-PAGE 
A one-dimensional gel of EP-12 is shown in 
fig.3a. EP-12 has an apparent M, of 12000 when 
compared to PV (Mr 12000). Two-dimensional 
PAGE of EP-12 (not shown) indicated that EP-12 
has an apparent isoelectric point at pH 4.5, slightly 
more acid than PV (pZ 4.9). 
3.2.3. Immunoblotting 
Fig.3 shows that the anti-EP serum reacted only 
with EP-12 (fig.3d), and not with either PV (fig.3e) 
or Ca (fig.3f). The anti-PV serum (fig.3g-i) only 
reacted with parvalbumin. CaM reacted with 
neither antiserum (fig.3f,i). An antiserum raised 
earlier against SCaBP cross-reacted with both 
EP-12 and PV (not shown). 
23 
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Fig.%. HPLC of purified EP-12 isolated from (a) the 
epidermis of the skin of adult rats (10 pg), (b) whole skin 
of newborn rats (10 pg), (c) rat muscle PV (6 pg), (d) ox 
brain calmodulin (6pg) and (e) buffer blank. A Tris- 
HCl/EGTA, pH 7.4, buffer system was used. The 
gradient was O-100% in 15 min. 
3.2.4. Calcium binding 
EP-12 (fig.3k) binds 45Ca when analyzed by the 
transblot method. The affinity appeared to be 
somewhat lower than that of PV (fig.31) and Ca 
(fig.3m) as a 2-5-fold higher protein concentration 
was required for a visible 4sCa signal. 
3.2.5. Amino acid composition 
The amino acid compositions of EP-12, PV and 
rat epidermal thiol proteinase inhibitor (TPI) are 
-12K 
Fig.3. Immunological and 4’Ca binding properties. 1D 
SDS-PAGE (15%) of purified proteins: (a) EP-12 (3 pg) 
from newborn rats, (b) rat muscle PV (2pg) and (c) 
calmodulin (2 pg) 14C-labeled and visualized by 
fluorography. Immunoblotting: same order of proteins 
(but in concentrations of 2, 3 and lO,~g, respectively) 
were transferred to nitrocellulose followed by incubation 
with anti EP-12 serum (d-f) and with anti rat muscle PV 
serum (g-i). Immunoreaction was visualized by 
incubation with a second antibody (peroxidase-coupled 
goat anti-rabbit IgG) and the color reaction developed 
with chloronaphthol. 45Ca-transblot: same order but 
concentrations of 5, 1 and 2 pg of protein were blotted 
to nitrocellulose and incubated with 45Ca to detect 
calcium-binding proteins by autoradiography (k-m). 
shown in table 1. There are a number of dif- 
ferences between EP-12 and PV, notably in their 
contents of Lys, Glu and Pro, but similarities to 
TPI. 
3.2.6. Immunohistochemistry 
EP-12 immunoreactivity was observed in the 
epidermis of rat skin, but the dermis and striated 
cutaneous muscle (panniculus carnosus) layers 
were unreactive (fig.4). Identical results were ob- 
tained with newborn (fig.4a) and adult (not shown) 
rat skin. Affinity-purified EP-12 antibodies gave 
the same results (not shown). Anti-PV serum 
stained neither the epidermis nor the muscle layer 
of newborn rat skin (fig.4b). However, the muscle 
layer and some nerve endings of adult rat skin were 
deeply stained with anti-PV serum, while the 
epidermis and dermis remained unstained (figl4d). 
No staining was observed with anti-EP-12 serum in 
a number of other rat tissues, including brain, 
Fig.4. Immunohistochemical localization. Newborn rat skin incubated with (a) anti-EP-12 serum and (b) anti-PV serum. 
Only the epidermis (E) displayed EP-12 immunoreactivity (a). When newborn skin was incubated with anti-muscle PV 
serum (b) the epidermis remained unstained. In adult skin (d) a thin layer of muscle tissue in the reticular layer of the 
cutis (panniculus carnosus) reacted. No immunoreactivity was found in newborn (c) skin incubated with preimmune 
sera. (a-c) Bouin-fixation, (d) freeze-substitution. E, epidermis; D, dermis; M, striated cutaneous muscle layer. 
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Table 1 
Amino acid composition of rat epidermal protein EP-12, 
parvalbumin (PV) and thiol proteinase inhibitor (TPI) 
Amino acid EP-12* PVb TPIC 
Lysine 8.7 16 13 
Histidine 1.7 2 1 
Arginine 3.5 1 3 
Aspartic acid 14.0 14 13 
Threonine 5.7 5 7 
Serine 7.7 11 3 
Glutamic acid 17.3 8 14 
Proline 4.1 0 3 
Glycine 8.1 9 9 
Alanine 6.6 11 4 
Valine 8.0 5 11 
Methionine 3.0 3 3 
Isoleucine 5.1 6 3 
Leucine 8.0 9 9 
Tyrosine 1.5 0 3 
Phenylalanine 4.8 8 4 
Tryptophan not 
determined 0 
Cysteine not 
determined 0 
a kf, of 12000 was used for calculations 
b Taken from sequence data [29] 
’ Taken from sequence data [26] 
muscle and kidney. Some staining was seen in liver 
and intestine. In contrast, anti-PV serum 
specifically stained muscle (fast-twitch fibres), 
kidney (part of the distal tubule and proximal col- 
lecting duct) and brain (subpopulation of 
neurons), as was reported previously [18]. 
4. DISCUSSION 
This report describes for the first time the 
purification of an epidermal protein EP-12 (Mr 
12000) from the epidermis of adult rats and from 
whole skin of newborn rats. EP-12 is distinct from 
PV in several biochemical and immunological 
properties. In contrast to a variety of other 
Ca’+-binding proteins, including PV, this protein 
gave a weak signal in the 45Ca transblot elec- 
trophoresis, suggesting a lower affinity for Ca*+. 
The contradictory results obtained previously are 
now clarified by the present data. SCaBP, isolated 
26 
previously from total skin of adult rats, was a mix- 
ture of EP-12 (located in the epidermis) and PV 
(located in the striated cutaneous muscle). This ex- 
plains why previous anti-SCaBP sera cross-reacted 
with EP-12 and PV and stained epidermis, neurons 
in the brain and fast-twitch fibres in skeletal mus- 
cle, as an anti-PV serum. The specific anti-EP-12 
serum only stained the epidermis of adult and 
newborn rats, but not muscle and brain. Other 
epithelial cells, e.g. in intestine and tongue, were 
also EP-12 immunoreactive indicating that this 
protein may not be specific to the epidermis. The 
present results will allow one to reinvestigate 
whether the synthesis of EP-12 in the skin may de- 
pend on vitamin D, as has been reported for the 
SCaBP [ 191. 
The identity of EP-12 is presently not known. 
There are however, several low molecular mass 
proteins which have been described in the epider- 
mis, e.g., epidermal cysteine-rich proteins [20,21], 
keratolin [22], a phospholipase A2 [23], retinol 
binding proteins [24], as well as lymphokines [25]. 
The properties of most of these components are 
distinct from EP-12. The amino acid composition 
of EP-12, however, closely resembles that of rat 
epidermal thiol proteinase inhibitor (TPI, M, 
10000-12000) [26]. The amino acid sequence of 
rat epidermal TPI was found to be homologous 
(but not identical) to either rat liver 1271, or human 
leucocyte TPI [28], and it was suggested that rat 
epidermal TPI may represent a new type of low 
molecular mass TPI [26]. The strongest immuno- 
staining of the anti EP-12 serum was observed in 
the epidermis, however, a specific staining was also 
observed in liver and intestine. These two tissues 
also contain suitable amounts of the low molecular 
mass TPIs which may be immunologically related 
to EP-12 or TPI from rat epidermis. The elucida- 
tion of the amino acid sequence of EP-12 will be 
undertaken for a direct comparison with the se- 
quence of rat epidermal TPI. 
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